Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review

I Iheanacho, S Zhang, D King, M Rizzo… - International journal of …, 2020 - Taylor & Francis
Background and Objectives Chronic obstructive pulmonary disease (COPD) affects over 250
million people globally, carrying a notable economic burden. This systematic literature …

Management of chronic obstructive pulmonary disease: A review focusing on exacerbations

SG Bollmeier, AP Hartmann - American Journal of Health …, 2020 - academic.oup.com
Purpose Chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity
and mortality in the United States. Exacerbations—acute worsening of COPD symptoms …

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind …

D Singh, A Papi, M Corradi, I Pavlišová, I Montagna… - The Lancet, 2016 - thelancet.com
Background Few data are available for the efficacy of" triple therapy" with two long-acting
bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease …

The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature

A ur Rehman, MA Ahmad Hassali… - Expert review of …, 2020 - Taylor & Francis
Background: Lack of information about economic burden of COPD is a major cause of lack
of attention to this chronic condition from governments and policymakers. Objective: To find …

The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications

V Kim, GJ Criner - Current opinion in pulmonary medicine, 2015 - journals.lww.com
The chronic bronchitis phenotype in chronic obstructive pulm... : Current Opinion in Pulmonary
Medicine The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features …

Relationship of blood eosinophil count to exacerbations in chronic obstructive pulmonary disease

RS Zeiger, TN Tran, RK Butler, M Schatz, Q Li… - The Journal of Allergy …, 2018 - Elsevier
Background Eosinophilic airway inflammation characterizes a chronic obstructive pulmonary
disease (COPD) phenotype that requires more study. Objective To investigate the …

Diagnostic accuracy of liquid biomarkers in airway diseases: toward point-of-care applications

V Landry, P Coburn, K Kost, X Liu… - Frontiers in …, 2022 - frontiersin.org
Background Liquid biomarkers have shown increasing utility in the clinical management of
airway diseases. Salivary and blood samples are particularly amenable to point-of-care …

Patterns and economic burden of hospitalizations and exacerbations among patients diagnosed with idiopathic pulmonary fibrosis

YF Yu, N Wu, CC Chuang, R Wang, X Pan… - Journal of Managed …, 2016 - jmcp.org
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a rare and fatal restrictive respiratory
disease under the idiopathic lung disease (ILD) class. IPF is a form of chronic, progressive …

Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL)

T Yang, B Cai, B Cao, J Kang, F Wen… - Therapeutic …, 2023 - journals.sagepub.com
Background: Chronic obstructive pulmonary disease (COPD) management in China is
inadequate and there is a need to improve care and outcomes for patients nationwide …

System and method for outpatient management of chronic disease

M Cutaia - US Patent 10,136,859, 2018 - Google Patents
An outpatient ambulatory patient worn apparatus for managing chronic lung disease
includes a plurality of sensors configured to be worn by a patient and to measure a plurality …